See other companies on Welcome to the Jungle
Smart Reporting
Automated structured medical reporting
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- SaaS
- Automation
- Altstadt-Lehel, Munich, Germany
Jump to section
Company mission
To use the value of data generated in medicine to optimize decision making and treatment for the best possible outcome for patients.
Our take
It is no secret that healthcare professionals spend an obscene amount of time on administrative tasks, which is why a number of companies are looking to bring automation to the sector. Smart Reporting is one such company, delivering data-driven, automated medical reporting to streamline the process and free up professionals so they can concentrate on their patients.
Where Smart Reporting catches the eye is that its solution not only speeds up reporting but also helps enhance the quality of reports and support better decision making. This in turn contributes to better care and patient outcomes, making the healthcare system work better for everyone.
Already regarded as a leader in the market, Smart Reporting is looking to expand its presence in the US, Canada, Australia and New Zealand. A significant Series C fundraise will support it in this endeavour. It has also strengthened its management team and intends to grow its portfolio of products in the future.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Performance-based bonus scheme
- Flexibility including fully remote options
- Individual development budget to support your professional growth
- Positive, highly skilled and international team
- Meaningful work that positively impacts healthcare and people’s lives
- Opportunity to contribute to a cutting-edge medical software product with rapid growth and significant funding
Funding (last 2 of 7 rounds)
Apr 2024
$24m
SERIES C
Apr 2020
$15.7m
SERIES B
Total funding: $52.3m
Leadership
Wieland Sommer
(Founder & Co-CEO)Founder and Board Member of Planerio. Also Professor in Radiology at Ludwig-Maximilians-Universität München.
Peter Vanovertveld
(Co-CEO, not founder)Was previously CCO and COO of the company. Prior to this, was SVP of Global Pricing and Market Access at Vifor Pharma.